Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6MB0

Crystal structure of N-myristoyl transferase (NMT) G386E mutant from Plasmodium vivax in complex with inhibitor IMP-1002

6MB0 の概要
エントリーDOI10.2210/pdb6mb0/pdb
分子名称Glycylpeptide N-tetradecanoyltransferase, TETRADEC-13-YNOIC ACID - COA THIOESTER, 1-(5-{4-fluoro-2-[2-(1,3,5-trimethyl-1H-pyrazol-4-yl)ethoxy]phenyl}-1-methyl-1H-indazol-3-yl)-N,N-dimethylmethanamine, ... (7 entities in total)
機能のキーワードssgcid, glycylpeptide n-tetradecanoyltransferase, n-myristoyltransferase, nmt, salvador i, structural genomics, seattle structural genomics center for infectious disease, transferase
由来する生物種Plasmodium vivax
タンパク質・核酸の鎖数3
化学式量合計146619.83
構造登録者
Seattle Structural Genomics Center for Infectious Disease (SSGCID) (登録日: 2018-08-29, 公開日: 2019-06-05, 最終更新日: 2024-03-13)
主引用文献Schlott, A.C.,Mayclin, S.,Reers, A.R.,Coburn-Flynn, O.,Bell, A.S.,Green, J.,Knuepfer, E.,Charter, D.,Bonnert, R.,Campo, B.,Burrows, J.,Lyons-Abbott, S.,Staker, B.L.,Chung, C.W.,Myler, P.J.,Fidock, D.A.,Tate, E.W.,Holder, A.A.
Structure-Guided Identification of Resistance Breaking Antimalarial N‐Myristoyltransferase Inhibitors.
Cell Chem Biol, 26:991-, 2019
Cited by
PubMed Abstract: The attachment of myristate to the N-terminal glycine of certain proteins is largely a co-translational modification catalyzed by N-myristoyltransferase (NMT), and involved in protein membrane-localization. Pathogen NMT is a validated therapeutic target in numerous infectious diseases including malaria. In Plasmodium falciparum, NMT substrates are important in essential processes including parasite gliding motility and host cell invasion. Here, we generated parasites resistant to a particular NMT inhibitor series and show that resistance in an in vitro parasite growth assay is mediated by a single amino acid substitution in the NMT substrate-binding pocket. The basis of resistance was validated and analyzed with a structure-guided approach using crystallography, in combination with enzyme activity, stability, and surface plasmon resonance assays, allowing identification of another inhibitor series unaffected by this substitution. We suggest that resistance studies incorporated early in the drug development process help selection of drug combinations to impede rapid evolution of parasite resistance.
PubMed: 31080074
DOI: 10.1016/j.chembiol.2019.03.015
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.55 Å)
構造検証レポート
Validation report summary of 6mb0
検証レポート(詳細版)ダウンロードをダウンロード

249697

件を2026-02-25に公開中

PDB statisticsPDBj update infoContact PDBjnumon